Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma

Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma

Background: Lung cancer is the leading cause of cancer-related deaths worldwide with poor prognosis. Programmed cell death (PCD) plays a crucial function in tumor progression and immunotherapy response in lung adenocarcinoma (LUAD). Methods: Integrative machine learning procedure including 10 method...

Full description

Bibliographic Details
Main Authors: Dongxiao Ding, Liangbin Wang, Yunqiang Zhang, Ke Shi, Yaxing Shen
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Translational Oncology
Subjects:
Programmed cell death
Machine learning
Lung adenocarcinoma
Prognostic signature
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323001705

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323001705

Similar Items